Infliximab treatment of severe ankylosing spondylitis: one-year followup
- PMID: 11762956
- DOI: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m
Infliximab treatment of severe ankylosing spondylitis: one-year followup
Comment in
-
Case series of selective anti-tumor necrosis factor alpha therapy using infliximab in patients with nonresponsive chronic HLA-B27-associated anterior uveitis: comment on the articles by Brandt et al.Arthritis Rheum. 2002 Oct;46(10):2821-2; author reply 2822-4. doi: 10.1002/art.10469. Arthritis Rheum. 2002. PMID: 12384949 No abstract available.
Comment on
-
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.Arthritis Rheum. 2000 Jun;43(6):1346-52. doi: 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E. Arthritis Rheum. 2000. PMID: 10857793 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
